Caas Capital Management LP Moderna, Inc. Call Options Transaction History

Caas Capital Management LP

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Oct 28, 2024	SELL	$63.64 - $125.14 $133,644 - $262,794	-2,100 Reduced 11.67%	15,900 $1.06 Million
Q2 2024 Jul 15, 2024	SELL	$101.21 - $166.61 $829,922 - $1.37 Million	-8,200 Reduced 31.3%	18,000 $2.14 Million
Q1 2024 Apr 26, 2024	BUY	$85.37 - $115.44 $2.24 Million - $3.02 Million	26,200 New	26,200 $2.79 Million
Q1 2023 May 15, 2023	BUY	$135.66 - $197.02 $3.34 Million - $4.85 Million	24,600 New	24,600 $3.78 Million
Q3 2022 Nov 14, 2022	SELL	$118.07 - $194.18 $9.86 Million - $16.2 Million	-83,500 Reduced 74.09%	29,200 $3.45 Million
Q2 2022 Aug 15, 2022	BUY	$117.13 - $176.59 $12.8 Million - $19.2 Million	109,000 Added 2945.95%	112,700 $16.1 Million
Q1 2022 May 13, 2022	BUY	$126.46 - $235.05 $50,584 - $94,020	400 Added 12.12%	3,700 $638,000
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $745,206 - $1.22 Million	3,300 New	3,300 $838,000

953

240M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Caas Capital Management LP with notifications on news.